Systems biology of human atherosclerosis

Vascular and Endovascular Surgery

Volumn 48, Issue 1, 2014, Pages 5-17

  Shalhoub, Joseph ^a   Sikkel, Markus B ^b   Davies, Kerry J ^a   Vorkas, Panagiotis A ^a   Want, Elizabeth J ^a   Davies, Alun H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

atherosclerosis; genomics; metabolomics; metabonomics; proteomics; systems biology; transcriptomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHOLESTEROL ESTER TRANSFER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; PROTEIN;

ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; FAMILIAL HYPERCHOLESTEROLEMIA; FLUID INTAKE; GENE EXPRESSION; GENETIC VARIABILITY; GENOMICS; LIPID METABOLISM; MASS SPECTROMETRY; NONHUMAN; NUTRITIONAL STATUS; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL NETWORK; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; METABOLOMICS; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS;

ATHEROSCLEROSIS; BIOMARKERS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; METABOLOMICS; PROGNOSIS; PROTEIN INTERACTION MAPS; PROTEOMICS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; SYSTEMS INTEGRATION;

EID: 84890926667     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413510628     Document Type: Review

References (82)

1. Narula J, Strauss HW. The popcorn plaques. Nat Med. 2007 ; 13 (5). 532-534
2. Shalhoub J, Davies KJ, Hasan N, Thapar A, Sharma P, Davies AH. The utility of collaborative biobanks for cardiovascular research. Angiology. 2012 ; 63 (5). 367-377
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126
4. Anderson PW. More is different. Science. 1972 ; 177 (4047). 393-396
5. Prigogine I, Stengers I La nouvelle alliance. Paris: Editions Gallimard ; 1979:
6. Ferrell JE. Systems biology. J Biol. 2009 ; 8 (1). 2
7. Kirschner MW. The meaning of systems biology. Cell. 2005 ; 121 (4). 503-504
8. Varki A, Altheide TK. Comparing the human and chimpanzee genomes: Searching for needles in a haystack. Genome Res. 2005 ; 15 (12). 1746-1758
9. Lander AD. The edges of understanding. BMC Biol. 2010 ; 8: 40
10. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature. 1999 ; 402 (6761 suppl). C47 - C52
11. Soutar AK, Naoumova RP. Mechanisms of disease: Genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med. 2007 ; 4 (4). 214-225
12. De Keulenaer GW, Brutsaert DL. Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum. Circulation. 2011 ; 123 (18). 1996-2004
13. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the fto gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007 ; 316 (5826). 889-894
14. Barabasi AL. Network medicine - from obesity to the "diseasome" . N Engl J Med. 2007 ; 357 (4). 404-407
15. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007 ; 357 (4). 370-379
16. Lusis AJ, Weiss JN. Cardiovascular networks: Systems-based approaches to cardiovascular disease. Circulation. 2010 ; 121 (1). 157-170
17. Strogatz SH. Exploring complex networks. Nature. 2001 ; 410 (6825). 268-276
18. Ramsey SA, Klemm SL, Zak DE, et al. Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics. PLoS Comput Biol. 2008 ; 4 ( 3 ):
19. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006 ; 355 (25). 2615-2617
20. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008 ; 451 (7181). 949-952
21. Pepe MS, Thompson ML. Combining diagnostic test results to increase accuracy. Biostatistics. 2000 ; 1 (2). 123-140
22. Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 2004 ; 3 (4). 227-235
23. Kostulas K, Brophy VH, Moraitis K, et al. Genetic profile of ischemic cerebrovascular disease and carotid stenosis. Acta Neurol Scand. 2008 ; 118 (3). 146-152
24. Lanktree MB, Hegele RA, Yusuf S, Anand SS. Multi-ethnic genetic association study of carotid intima-media thickness using a targeted cardiovascular snp microarray. Stroke. 2009 ; 40 (10). 3173-3179
25. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009 ; 41 (6). 666-676
26. Archacki SR, Wang QK. Microarray analysis of cardiovascular diseases. Methods Mol Med. 2006 ; 129: 1-13
27. Archacki SR, Angheloiu G, Tian XL, et al. Identification of new genes differentially expressed in coronary artery disease by expression profiling. Physiol Genomics. 2003 ; 15 (1). 65-74
28. Randi AM, Biguzzi E, Falciani F, et al. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cdna array analysis. J Thromb Haemost. 2003 ; 1 (4). 829-835
29. Archacki S, Wang Q. Expression profiling of cardiovascular disease. Hum Genomics. 2004 ; 1 (5). 355-370
30. Hiltunen MO, Tuomisto TT, Niemi M, et al. Changes in gene expression in atherosclerotic plaques analyzed using DNA array. Atherosclerosis. 2002 ; 165 (1). 23-32
31. Fu S, Zhao H, Shi J, et al. Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses. BMC Genomics. 2008 ; 9: 369
32. Tabibiazar R, Wagner RA, Ashley EA, et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics. 2005 ; 22 (2). 213-226
33. Bijnens AP, Lutgens E, Ayoubi T, Kuiper J, Horrevoets AJ, Daemen MJ. Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol. 2006 ; 26 (6). 1226-1235
34. Seo D, Wang T, Dressman H, et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004 ; 24 (10). 1922-1927
35. Sluimer JC, Kisters N, Cleutjens KB, et al. Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. Physiol Genomics. 2007 ; 30 (3). 335-341
36. Papaspyridonos M, Smith A, Burnand KG, et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006 ; 26 (8). 1837-1844
37. Rossi L, Lapini I, Magi A, et al. Carotid artery disease: Novel pathophysiological mechanisms identified by gene-expression profiling of peripheral blood. Eur J Vasc Endovasc Surg. 2010 ; 40 (5). 549-558
38. Faber BC, Cleutjens KB, Niessen RL, et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res. 2001 ; 89 (6). 547-554
39. Bagnato C, Thumar J, Mayya V, et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007 ; 6 (6). 1088-1102
40. You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics. 2003 ; 13 (1). 25-30
41. Martinez-Pinna R, Barbas C, Blanco-Colio LM, et al. Proteomic and metabolomic profiles in atherothrombotic vascular disease. Curr Atheroscler Rep. 2010 ; 12 (3). 202-208
42. Stegemann C, Drozdov I, Shalhoub J, et al. Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet. 2011 ; 4 (3). 232-242
43. Abdul-Salam VB, Ramrakha P, Krishnan U, et al. Identification and assessment of plasma lysozyme as a putative biomarker of atherosclerosis. Arterioscler Thromb Vasc Biol. 2010 ; 30 (5). 1027-1033
44. Chen X, Liu L, Palacios G, et al. Plasma metabolomics reveals biomarkers of the atherosclerosis. J Sep Sci. 2010 ; 33 (17-18). 2776-2783
45. Lepedda AJ, Cigliano A, Cherchi GM, et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis. 2009 ; 203 (1). 112-118
46. Mayr M, Grainger D, Mayr U, et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet. 2009 ; 2 (4). 379-388
47. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1h-nmr-based metabonomics. Nat Med. 2002 ; 8 (12). 1439-1444
48. Didangelos A, Simper D, Monaco C, Mayr M. Proteomics of acute coronary syndromes. Curr Atheroscler Rep. 2009 ; 11 (3). 188-195
49. Didangelos A, Stegemann C, Mayr M. The -omics era: proteomics and lipidomics in vascular research. Atherosclerosis. 2011 ; 221 (1). 12-17
50. Martin-Ventura JL, Duran MC, Blanco-Colio LM, et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation. 2004 ; 110 (15). 2216-2219
51. Didangelos A, Yin X, Mandal K, Baumert M, Jahangiri M, Mayr M. Proteomics characterization of extracellular space components in the human aorta. Mol Cell Proteomics. 2010 ; 9 (9). 2048-2062
52. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008 ; 455 (7216). 1054-1056
53. Nicholson JK, Lindon JC. Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological nmr spectroscopic data. Xenobiotica. 1999 ; 29 (11). 1181-1189
54. Chan EC, Pasikanti KK, Nicholson JK. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc. 2011 ; 6 (10). 1483-1499
55. Lindon JC, Holmes E, Nicholson JK. Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res. 2006 ; 23 (6). 1075-1088
56. Hirai MY, Klein M, Fujikawa Y, et al. Elucidation of gene-to-gene and metabolite-to-gene networks in arabidopsis by integration of metabolomics and transcriptomics. J Biol Chem. 2005 ; 280 (27). 25590-25595
57. Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling, metabolomic and metabonomic procedures for nmr spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007 ; 2 (11). 2692-2703
58. Beckonert O, Coen M, Keun HC, et al. High-resolution magic-angle-spinning nmr spectroscopy for metabolic profiling of intact tissues. Nat Protoc. 2010 ; 5 (6). 1019-1032
59. Goonewardena SN, Prevette LE, Desai AA. Metabolomics and atherosclerosis. Curr Atheroscler Rep. 2010 ; 12 (4). 267-272
60. Schmidt C. Metabolomics takes its place as latest up-and-coming "omic" science. J Natl Cancer Inst. 2004 ; 96 (10). 732-734
61. Bunch J, Clench MR, Richards DS. Determination of pharmaceutical compounds in skin by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom. 2004 ; 18 (24). 3051-3060
62. McDonnell LA, Heeren RM. Imaging mass spectrometry. Mass Spectrom Rev. 2007 ; 26 (4). 606-643
63. Trim PJ, Djidja MC, Atkinson SJ, et al. Introduction of a 20 khz nd: Yvo4 laser into a hybrid quadrupole time-of-flight mass spectrometer for maldi-ms imaging. Anal Bioanal Chem. 2010 ; 397 (8). 3409-3419
64. Trim PJ, Henson CM, Avery JL, et al. Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem. 2008 ; 80 (22). 8628-8634
65. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S. Systematic subcellular localization of novel proteins identified by large-scale cdna sequencing. EMBO Rep. 2000 ; 1 (3). 287-292
66. Kumar A, Agarwal S, Heyman JA, et al. Subcellular localization of the yeast proteome. Genes Dev. 2002 ; 16 (6). 707-719
67. Djidja MC, Claude E, Snel MF, et al. Novel molecular tumour classification using maldi-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem. 2010 ; 397 (2). 587-601
68. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 2001 ; 7 (4). 493-496
69. Grey AC, Gelasco AK, Section J, Moreno-Rodriguez RA, Krug EL, Schey KL. Molecular morphology of the chick heart visualized by maldi imaging mass spectrometry. Anat Rec (Hoboken). 2010 ; 293 (5). 821-828
70. Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004 ; 306 (5695). 471-473
71. Manicke NE, Nefliu M, Wu C, et al. Imaging of lipids in atheroma by desorption electrospray ionization mass spectrometry. Anal Chem. 2009 ; 81 (21). 8702-8707
72. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007 ; 6 (2). 469-479
73. van der Greef J, Smilde AK. Symbiosis of chemometrics and metabolomics: past, present, and future. J Chemometrics. 2005 ; 19 (5-7). 376-386
74. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics. 2001 ; 17 (9). 763-774
75. Scholz M, Selbig J. Visualization and analysis of molecular data. Methods Mol Biol. 2007 ; 358: 87-104
76. Jolliffe IT Principal component analysis. New York: Springer ; 2002:
77. Lutz U, Lutz RW, Lutz WK. Metabolic profiling of glucuronides in human urine by lc-ms/ms and partial least-squares discriminant analysis for classification and prediction of gender. Anal Chem. 2006 ; 78 (13). 4564-4571
78. Bylesjo M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. Opls discriminant analysis: Combining the strengths of pls-da and simca classification. J Chemometrics. 2006 ; 20 (8-10). 341-351
79. Eriksson L. Cv-anova for significance testing of pls and opls® models. J Chemometrics. 2008 ; 22 (11-12). 594-600
80. Blaise BJ, Shintu L, Elena Bnd, Emsley L, Dumas M-E, Toulhoat P. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. Anal Chem. 2009 ; 81 (15). 6242-6251
81. Schadt EE, Lamb J, Yang X, et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet. 2005 ; 37 (7). 710-717
82. Yang X, Deignan JL, Qi H, et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet. 2009 ; 41 (4). 415-423